The pitfalls of growing nanomaterials

Nanomedicine

Volumn 11, Issue 13, 2016, Pages 1635-1638

  Shiekh, Farooq A ^a   Farooq, Omar ^b   Mian, Sarah H ^a   Bautista, Roxanne L ^a   Arja, Sateesh B ^a   Andrabi, Khurshid I ^c  

^a Department of Basic Medical Sciences ^*  (Netherlands)

^b GOVERNMENT MEDICAL COLLEGE   (India)

^c UNIVERSITY OF KASHMIR   (India)

Author keywords

nanomaterials; nanomedicine; nanorisks; nanotechnology; nanotoxicity

Indexed keywords

DOXORUBICIN; GOLD NANOPARTICLE; IMMUNOLIPOSOME; KETOCONAZOLE; NANOMATERIAL; NANOPARTICLE; QUANTUM DOT; REACTIVE OXYGEN METABOLITE;

CANCER THERAPY; DRUG DELIVERY SYSTEM; ENVIRONMENTAL HEALTH; HEALTH HAZARD; HUMAN; MEDICAL RESEARCH; NANOENGINEERING; NANOMEDICINE; NANOTECHNOLOGY; NOTE; PRIORITY JOURNAL; RISK ASSESSMENT; DRUG DEVELOPMENT; SAFETY; TRENDS;

DRUG DISCOVERY; HUMANS; NANOMEDICINE; NANOSTRUCTURES; NANOTECHNOLOGY; RISK ASSESSMENT; SAFETY;

EID: 84978427534     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm-2016-0043     Document Type: Note

References (32)

1. Mulleneisen NK. The new GOLD standard recommendation is not implemented in everyday life. Pneumologie 67(4), 241-242 (2013).
2. Blaustein AR, Dobson A. Extinctions: a message from the frogs. Nature 439(7073), 143-144 (2006).
3. Maynard AD, Aitken RJ, Butz T et al. Safe handling of nanotechnology. Nature 444(7117), 267-269 (2006).
4. Roberts J, Bagci E, Zawawi MA et al. Using quantum confnement to uniquely identify devices. Sci. Rep. 5, 16456 (2015).
5. Lai CY, Santos S, Chiesa M. Reconstruction of height of sub-nanometer steps with bimodal atomic force microscopy. Nanotechnology 27(7), 075701 (2016).
6. Walt DR. Chemistry. Miniature analytical methods for medical diagnostics. Science 308(5719), 217-219 (2005).
7. Wright J. Deliver on a promise. Sci. Am. 311(1), S12-S13 (2014).
8. Miller MA, Gadde S, Pfrschke C et al. Predicting therapeutic nanomedicine effcacy using a companion magnetic resonance imaging nanoparticle. Sci. Transl. Med. 7(314), 314ra183 (2015).
9. Aires A, Ocampo SM, Simoes BM et al. Multifunctionalized iron oxide nanoparticles for selective drug delivery to CD44-positive cancer cells. Nanotechnology 27(6), 065103 (2016).
10. Rolle AM, Hasenberg M, Thornton CR et al. ImmunoPET/MR imaging allows specifc detection of Aspergillus fumigatus lung infection in vivo. Proc. Natl Acad. Sci. USA 113 (8), E1026-E1033 (2016).
11. Shi D, Xu X, Ye Y et al. Photo-cross-linked scaffold with kartogenin-encapsulated nanoparticles for cartilage regeneration. ACS Nano. 10(1), 1292-1299 (2016).
12. Service RF. Nanotechnology. Calls rise for more research on toxicology of nanomaterials. Science 310(5754), 1609 (2005).
13. Zhang YN, Poon W, Tavares AJ et al. Nanoparticle-liver interactions: Cellular uptake and hepatobiliary elimination. J. Control. Release doi:10.1016/j.jconrel.2016.01.020 (2016) (Epub ahead of print).
14. Gibbs JB. Mechanism-based target identifcation and drug discovery in cancer research. Science 287(5460), 1969-1973 (2000).
15. Shiekh FA. Synthetic nanocarriers as a new paradigm. Nanomedicine (Lond.) 9(15), 2259-2262 (2014).
16. Shiekh FA, Mian SH, Arja SB et al. Targeted combination nanotherapeutics in cancer a real promise. Nanomedicine (Lond.) 10 (12), 1855-1857 (2015).
17. Tietjen GT, Saltzman WM. Nanomedicine gets personal. Sci. Transl. Med. 7(314), 314fs47 (2015).
18. Bourzac K. Nanotechnology: carrying drugs. Nature 491(7425), S58-S60 (2012).
19. Pearce JM. Make nanotechnology research open-source. Nature 491, 519-521 (2012).
20. Dresselhaus MS. A revolution of nanoscale dimensions. Nat. Rev. Mater. 1, 15017 (2016).
21. Shiekh FA. Highlights from recent advances in nanomedicine. Nanomedicine (Lond.) 9(9), 1287-1289 (2014).
22. Sengupta S, Sasisekharan R. Exploiting nanotechnology to target cancer. Br. J. Cancer 96 (9), 1315-1319 (2007).
23. Trpkovic A, Todorovic-Markovic B, Trajkovic V. Toxicity of pristine versus functionalized fullerenes: mechanisms of cell damage and the role of oxidative stress. Arch. Toxicol. 86(12), 1809-1827 (2012).
24. Smith C. Tools for drug discovery: tools of the trade. Nature 446(7132), 219-222 (2007).
25. Yang CH, Wang LS, Chen SY et al. Microfuidic assisted synthesis of silver nanoparticle-chitosan composite microparticles for antibacterial applications. Int. J. Pharm. doi:10.1016/j.ijpha rm.2016.01.010 (2016) (Epub a head of pub).
26. Service RF. Materials and biology. Nanotechnology takes aim at cancer. Science 310(5751), 1132-1134 (2005).
27. Pinheiro AV, Han D, Shih WM et al. Challenges and opportunities for structural DNA nanotechnology. Nat. Nanotechnol. 6(12), 763-772 (2011).
28. Dong Y, Love K T, Dorkin JR et al. Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates. Proc. Natl Acad. Sci. USA 111(11), 3955-3960 (2014).
29. Pu K, Chattopadhyay N, Rao J. Recent advances of semiconducting polymer nanoparticles in In vivo molecular imaging. J. Control. Release doi:10.1016/j.jconrel.2016.01.004 (2016) (Epub ahead of print).
30. Samuel RE. Nano rules fall foul of data gap. Nature 480 (7376), 160-161 (2011).
31. Riego-Sintes J. Regulation: safety-test initiatives for nanomaterials. Nature 482(7383), 35 (2012).
32. Muhlebach S, Borchard G, Yildiz S. Regulatory challenges and approaches to characterize nanomedicines and their follow-on similars. Nanomedicine (Lond.) 10(4), 659-674 (2015).